HomeAI · summaries
Storia in 3 fonti
Health Care Up Amid Multibillion Dollar Oncology Deals - Health Care Roundup
Health-care companies rose as deal activity in the sector intensified.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Health Care Ticks Down Amid Deal Activity - Health Care Roundup
Health-care companies ticked down as deal activity offset fears about generic competition for one key category of drugs.
- ·
statnews.com
GSK to buy Nuvalent, maker of targeted cancer drugs, for $10.6B
GSK is buying Nuvalent, the maker of targeted cancer drugs, for $10.6 billion, a sizable addition to the latest run of biopharma acquisitions.
- ·
Gilead and Merck's latest trial success and flop
AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
- ·
Health Care Up Amid Multibillion Dollar Oncology Deals - Health Care Roundup
Health-care companies rose as deal activity in the sector intensified.
- ·
thisdaylive.com
GSK Boosts Cancer Portfolio, Acquires Nuvalent for $10.6 Billion
GSK Boosts Cancer Portfolio, Acquires Nuvalent for $10.6 Billion